Herceptin Biosimilars Market Key Players Analysis 2031
Herceptin is a monoclonal antibody, a cancer medication used in the treatment of breast cancer. Herceptin is called a "biologic" drug. It is made from a living organism and is also termed as a targeted therapy drug. Biologic drugs are very complex to make and very sensitive to change. A biosimilar is the biologic drug generic version. Herceptin is used as part of chemotherapy regimen for adjuvant treatment of lymph-node positive, protein-positive breast cancer and mainly administered intravenously in cancer patients; the dose of herceptin given to patients is evaluated based on patients' disease history and other physiological factors such as type of cancer or disease condition, height, and weight.
MARKET DYNAMICS
The rising prevalence of cancers such as breast cancer in women, rise in the cancer patient pool, and increasing demand for the targeted therapy are the major factor driving the growth of the global herceptin biosimilar market. Furthermore, the increasing prevalence of gastric cancers such as metastatic gastric cancer is the factor expected to propel the market's growth. Rising spending on research & development, changing lifestyle, increasing pollution, and adoption of smoking by the people will serve as fuel for the growth of the market. Due to the COVID-19 pandemic and lockdowns imposed by governments, the market experienced a decrease in sales. However, side effects associated with herceptin biosimilars such as pulmonary toxicity and embryo-fetal toxicity and the presence of alternatives are supposed to hinder the market growth over the forecast period.
MARKET SCOPE
The "Herceptin Biosimilars Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of herceptin biosimilars market with detailed market segmentation by type, and application. The herceptin biosimilars market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in herceptin biosimilars market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The herceptin biosimilars market is segmented on the basis of type, and application. On the basis of type, the market is segmented as breast cancer, gastric cancer, and others. On the basis of application, the market is segmented into hospitals and clinics, oncology centers, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the herceptin biosimilars market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The herceptin biosimilars market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting herceptin biosimilars market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the herceptin biosimilars market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the herceptin biosimilars market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The herceptin biosimilars market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting herceptin biosimilars market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the herceptin biosimilars market in these regions.
MARKET PLAYERS
The report covers key developments in the herceptin biosimilars market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from herceptin biosimilars market are anticipated to have lucrative growth opportunities in the future with the rising demand for herceptin biosimilars in the global market. Below mentioned is the list of few companies engaged in the herceptin biosimilars market.
The report also includes the profiles of key players in herceptin biosimilars market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Amgen Inc.
- AryoGen Biopharma
- Roche Holding AG
- Samsung bioepis Co,.Ltd.
- Biocon Limited
- Celltrion Inc.
- Pfizer Inc.
- Merck & Co., Inc.
- Gedeon Richter Plc
- Genor Biopharma Company Ltd
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Herceptin Biosimilars Market - By Type
1.3.2 Herceptin Biosimilars Market - By Application
1.3.3 Herceptin Biosimilars Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HERCEPTIN BIOSIMILARS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HERCEPTIN BIOSIMILARS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HERCEPTIN BIOSIMILARS MARKET - GLOBAL MARKET ANALYSIS
6.1. HERCEPTIN BIOSIMILARS - GLOBAL MARKET OVERVIEW
6.2. HERCEPTIN BIOSIMILARS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HERCEPTIN BIOSIMILARS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. BREAST CANCER
7.3.1. Overview
7.3.2. Breast Cancer Market Forecast and Analysis
7.4. GASTRIC CANCER
7.4.1. Overview
7.4.2. Gastric Cancer Market Forecast and Analysis
7.5. OTHERS.
7.5.1. Overview
7.5.2. Others. Market Forecast and Analysis
8. HERCEPTIN BIOSIMILARS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS AND CLINICS
8.3.1. Overview
8.3.2. Hospitals and clinics Market Forecast and Analysis
8.4. ONCOLOGY CENTERS
8.4.1. Overview
8.4.2. Oncology Centers Market Forecast and Analysis
8.5. OTHERS.
8.5.1. Overview
8.5.2. Others. Market Forecast and Analysis
9. HERCEPTIN BIOSIMILARS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Herceptin Biosimilars Market Overview
9.1.2 North America Herceptin Biosimilars Market Forecasts and Analysis
9.1.3 North America Herceptin Biosimilars Market Forecasts and Analysis - By Type
9.1.4 North America Herceptin Biosimilars Market Forecasts and Analysis - By Application
9.1.5 North America Herceptin Biosimilars Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Herceptin Biosimilars Market
9.1.5.1.1 Canada Herceptin Biosimilars Market by Type
9.1.5.1.2 Canada Herceptin Biosimilars Market by Application
9.1.5.2 Mexico Herceptin Biosimilars Market
9.1.5.2.1 Mexico Herceptin Biosimilars Market by Type
9.1.5.2.2 Mexico Herceptin Biosimilars Market by Application
9.1.5.3 US Herceptin Biosimilars Market
9.1.5.3.1 US Herceptin Biosimilars Market by Type
9.1.5.3.2 US Herceptin Biosimilars Market by Application
9.2. EUROPE
9.2.1 Europe Herceptin Biosimilars Market Overview
9.2.2 Europe Herceptin Biosimilars Market Forecasts and Analysis
9.2.3 Europe Herceptin Biosimilars Market Forecasts and Analysis - By Type
9.2.4 Europe Herceptin Biosimilars Market Forecasts and Analysis - By Application
9.2.5 Europe Herceptin Biosimilars Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Herceptin Biosimilars Market
9.2.5.1.1 Germany Herceptin Biosimilars Market by Type
9.2.5.1.2 Germany Herceptin Biosimilars Market by Application
9.2.5.2 France Herceptin Biosimilars Market
9.2.5.2.1 France Herceptin Biosimilars Market by Type
9.2.5.2.2 France Herceptin Biosimilars Market by Application
9.2.5.3 Italy Herceptin Biosimilars Market
9.2.5.3.1 Italy Herceptin Biosimilars Market by Type
9.2.5.3.2 Italy Herceptin Biosimilars Market by Application
9.2.5.4 Spain Herceptin Biosimilars Market
9.2.5.4.1 Spain Herceptin Biosimilars Market by Type
9.2.5.4.2 Spain Herceptin Biosimilars Market by Application
9.2.5.5 United Kingdom Herceptin Biosimilars Market
9.2.5.5.1 United Kingdom Herceptin Biosimilars Market by Type
9.2.5.5.2 United Kingdom Herceptin Biosimilars Market by Application
9.2.5.6 Rest of Europe Herceptin Biosimilars Market
9.2.5.6.1 Rest of Europe Herceptin Biosimilars Market by Type
9.2.5.6.2 Rest of Europe Herceptin Biosimilars Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Herceptin Biosimilars Market Overview
9.3.2 Asia-Pacific Herceptin Biosimilars Market Forecasts and Analysis
9.3.3 Asia-Pacific Herceptin Biosimilars Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Herceptin Biosimilars Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Herceptin Biosimilars Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Herceptin Biosimilars Market
9.3.5.1.1 Australia Herceptin Biosimilars Market by Type
9.3.5.1.2 Australia Herceptin Biosimilars Market by Application
9.3.5.2 China Herceptin Biosimilars Market
9.3.5.2.1 China Herceptin Biosimilars Market by Type
9.3.5.2.2 China Herceptin Biosimilars Market by Application
9.3.5.3 India Herceptin Biosimilars Market
9.3.5.3.1 India Herceptin Biosimilars Market by Type
9.3.5.3.2 India Herceptin Biosimilars Market by Application
9.3.5.4 Japan Herceptin Biosimilars Market
9.3.5.4.1 Japan Herceptin Biosimilars Market by Type
9.3.5.4.2 Japan Herceptin Biosimilars Market by Application
9.3.5.5 South Korea Herceptin Biosimilars Market
9.3.5.5.1 South Korea Herceptin Biosimilars Market by Type
9.3.5.5.2 South Korea Herceptin Biosimilars Market by Application
9.3.5.6 Rest of Asia-Pacific Herceptin Biosimilars Market
9.3.5.6.1 Rest of Asia-Pacific Herceptin Biosimilars Market by Type
9.3.5.6.2 Rest of Asia-Pacific Herceptin Biosimilars Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Herceptin Biosimilars Market Overview
9.4.2 Middle East and Africa Herceptin Biosimilars Market Forecasts and Analysis
9.4.3 Middle East and Africa Herceptin Biosimilars Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Herceptin Biosimilars Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Herceptin Biosimilars Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Herceptin Biosimilars Market
9.4.5.1.1 South Africa Herceptin Biosimilars Market by Type
9.4.5.1.2 South Africa Herceptin Biosimilars Market by Application
9.4.5.2 Saudi Arabia Herceptin Biosimilars Market
9.4.5.2.1 Saudi Arabia Herceptin Biosimilars Market by Type
9.4.5.2.2 Saudi Arabia Herceptin Biosimilars Market by Application
9.4.5.3 U.A.E Herceptin Biosimilars Market
9.4.5.3.1 U.A.E Herceptin Biosimilars Market by Type
9.4.5.3.2 U.A.E Herceptin Biosimilars Market by Application
9.4.5.4 Rest of Middle East and Africa Herceptin Biosimilars Market
9.4.5.4.1 Rest of Middle East and Africa Herceptin Biosimilars Market by Type
9.4.5.4.2 Rest of Middle East and Africa Herceptin Biosimilars Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Herceptin Biosimilars Market Overview
9.5.2 South and Central America Herceptin Biosimilars Market Forecasts and Analysis
9.5.3 South and Central America Herceptin Biosimilars Market Forecasts and Analysis - By Type
9.5.4 South and Central America Herceptin Biosimilars Market Forecasts and Analysis - By Application
9.5.5 South and Central America Herceptin Biosimilars Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Herceptin Biosimilars Market
9.5.5.1.1 Brazil Herceptin Biosimilars Market by Type
9.5.5.1.2 Brazil Herceptin Biosimilars Market by Application
9.5.5.2 Argentina Herceptin Biosimilars Market
9.5.5.2.1 Argentina Herceptin Biosimilars Market by Type
9.5.5.2.2 Argentina Herceptin Biosimilars Market by Application
9.5.5.3 Rest of South and Central America Herceptin Biosimilars Market
9.5.5.3.1 Rest of South and Central America Herceptin Biosimilars Market by Type
9.5.5.3.2 Rest of South and Central America Herceptin Biosimilars Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. HERCEPTIN BIOSIMILARS MARKET, KEY COMPANY PROFILES
11.1. AMGEN INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ARYOGEN BIOPHARMA
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ROCHE HOLDING AG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SAMSUNG BIOEPIS CO,.LTD.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BIOCON LIMITED
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. CELLTRION INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PFIZER INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MERCK AND CO., INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. GEDEON RICHTER PLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. GENOR BIOPHARMA COMPANY LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Amgen Inc.
2. AryoGen Biopharma
3. Roche Holding AG
4. Samsung bioepis Co,.Ltd.
5. Biocon Limited
6. Celltrion Inc.
7. Pfizer Inc.
8. Merck and Co., Inc.
9. Gedeon Richter Plc
10. Genor Biopharma Company Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For